Back to Top Skip to main content Skip to sub-navigation

Telemedicine advances put to the test during pandemic

Image of Uniformed service member stands behind wall of computer screens . Virtual health exercise at Madigan Army Medical Center. (U.S. Army photo)

Recommended Content:

Health Care Technology | Research and Innovation | Coronavirus and the COVID-19 Vaccine | Coronavirus and the COVID-19 Vaccine | Coronavirus | Coronavirus and the COVID-19 Vaccine | Health Innovation Toolkit

In the wake of the COVID-19 crisis, the Telemedicine and Advanced Technology Research Center continues to develop technology that increases medical capabilities and provides rapid, flexible critical care expertise at the point of need.

During a recent Medical Museum Science Café, held virtually by the National Museum of Health and Medicine in Silver Spring, Maryland, TATRC director Army Col. Jeremy Pamplin described the implementation of the National Emergency Tele-Critical Care Network (NETCCN) and how telemedicine can improve outcomes for disaster response.

COVID-19 has led to the need for physical distancing and has overwhelmed the capacities of health systems, compelling many to adopt telehealth solutions. Clinicians discovered how telemedicine can enhance communication efforts, reduce exposure and personal protective equipment consumption, improve efficiency and quality of care, increase access to specialty services, and in some cases lower costs and optimize the use of resources.

However, as Pamplin mentioned, the findings fluctuated due to the complex nature of the U.S. health system, which is an intricate mix of local, state, and federal policies and diverse expectations, cultures, and belief systems. For example, the implementation of telehealth may improve outcomes for one organization, whereas the same implementation elsewhere may not.

Pamplin described how he and his colleagues studied the implementation of telemedicine in a military environment.

“Telemedicine in the military has consistently enabled military clinicians around the world to work beyond their typical scope of practice while deployed in austere, resource limited environments by providing reach-back capability to military experts working in referral centers across the globe,” he said.

Pamplin then looked at the potential use of a telecritical health system for large-scale military operations. According to Pamplin, telehealth technology could be adapted to a variety of care contexts including large-scale combat situations or natural disasters that rely on military aid.

Partnering with the civilian sector, Pamplin and his colleagues developed NETCCN, a telehealth system that could consolidate telehealth networks and manage a high patient capacity during an emergency or a national crisis.

When COVID-19 emerged, Pamplin and his team began the implementation of NETCCN to help respond to the current stressed health care system. According to Pamplin, the network brings remote critical care expertise to the point of care, providing e-consult support, remote home monitoring, relief coverage, tiered staffing, and specialty services.

“The NETCCN addresses the lack of critical care clinicians across our nation by shifting these resources where and when needed,” Pamplin said. “In a dynamic, flexible fashion, NETCC links remote expertise to frontline providers, often working beyond their scope of training, using secure, HIPAA compliant applications on mobile devices, thus bypassing the lengthy process of purchasing and installing expensive hardware packages.

Said Andrea Schierkolk, NMHM’s public programs manager: “TATRC’s efforts to address the benefits and challenges of telemedicine were put to the test during the COVID-19 pandemic, and documenting these innovations in military medicine contributes to NMHM’s mission to share the value of the nation’s investment in programs like those of TATRC.”

For more information on TATRC and its initiatives, please visit at www.tatrc.org

You also may be interested in...

DHA-Policy Memorandum 21-004: Coronavirus Disease 2019 Vaccination Attestation, Screening Testing, and Vaccination Verification

Policy

This memorandum provides guidance on the implementation of vaccination, attestation, and testing requirements in accordance with the References listed in Attachment 1 to reduce the transmission of the virus that causes COVID-19.

8000.01

Policy

Information Technology Infrastructure Service Delivery Management Program

6205.01

Policy

Medical Logistics Guidance for the DoD Coronavirus Disease 2019 (COVID-19) Vaccination Program

20-004

Policy

Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation

DHA COVID19 Medical Coding PolicyV5 1v

Policy

Establishes the DHA procedures to standardize the coding for Coronavirus 2019 (COVID-19) within military medical treatment facilities (MTFs). This memorandum replaces DHA-Policy Memorandum 20-003 of July 1, 2020. Attachment 1 was updated to include the 2021 procedure and diagnosis codes for COVID-19, including the new vaccination and treatment codes.

  • Identification #: 20-003
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

TAB A MEO COVID19 Medical Coding Policy

Policy

Memorandum for DHA Staff - Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

  • Identification #: N/A
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

Supplemental Guidance for Providing DoD Coronavirus Disease 2019 Vaccines to DoD Contractor Employees and Select Foreign Nationals

Policy

This memorandum provides supplemental guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines, in accordance with reference (a). The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components as appropriate.

HA Guidance for Coronavirus Disease 2019 (COVID-19) Laboratory Pre-Testing Questionnaire

Policy

This memorandum provides guidance for a COVID-19 laboratory pre-testing questionnaire that will be mandatory for all Active Duty Service members and encouraged for all other DoD beneficiaries treated at military medical treatment facilities.

Executive Order on Ensuring Access to United States Government COVID-19 Vaccines

Policy

This EO outlines who should receive priority access to COVID-19 vaccines developed in the United States or procured by the United States Government (“United States Government COVID-19 Vaccines”).

Coronavirus Disease 2019 Vaccine Guidance

Policy

This memorandum provides guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines. The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components.

3020.01, Change 2

Policy

Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 Environment

  • Identification #: 3020.01
  • Date: 11/3/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

3020.01, Change 1

Policy

Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 Environment

  • Identification #: 3020.01
  • Date: 6/12/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

Policy

The Defense Health Agency (DHA) Memorandum, based on the authority of References (a) and (b), and in accordance with the guidance of References (c) and (d), establishes the DHA’s procedures to standardize the coding for Coronavirus 2019 (COVID-19) Military Medical Treatment Facilities (MTFs). This memorandum cancels and replaces DHA- Policy Memorandum 20-003 of (13 April 2020). A change was issued since the cancelled Memorandum 20-003 of (13 April 2020), the Attachment titles were updated to reflect that Attachments 1, 2, and 4 are considered Policies as opposed to Guidance.

  • Identification #: 20-003
  • Date: 5/13/2020
  • Type: Memorandums
  • Topics: Coronavirus

3200.01

Policy

Research and Development (R&D) Enterprise Activity (EA)

3201.05

Policy

Technology Transfer (T2) Program

<< < 1 2 > >> 
Showing results 1 - 15 Page 1 of 2
Refine your search
Last Updated: February 15, 2022

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.